Consun Pharmaceutical Group Limited

OTCPK:CPHG.F Stock Report

Market Cap: US$822.6m

Consun Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CPHG.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Nov 24BuyUS$519,833Lion River I N.V.Company491,000US$1.06
17 Sep 24BuyUS$70,126Meng AnIndividual92,000US$0.76
16 Sep 24BuyUS$259,563Meng AnIndividual350,000US$0.74
13 Sep 24BuyUS$219,409Meng AnIndividual295,000US$0.74
12 Sep 24BuyUS$622,011Meng AnIndividual856,000US$0.73
11 Sep 24BuyUS$738,400Meng AnIndividual1,021,000US$0.72
10 Sep 24BuyUS$370,052Meng AnIndividual518,000US$0.71
05 Sep 24BuyUS$196,415Meng AnIndividual290,000US$0.68
04 Sep 24BuyUS$595,079Meng AnIndividual830,000US$0.72
03 Sep 24BuyUS$724,519Meng AnIndividual1,009,000US$0.72
02 Sep 24BuyUS$687,208Meng AnIndividual950,000US$0.72
29 Aug 24BuyUS$64,861Meng AnIndividual90,000US$0.72
28 Aug 24BuyUS$244,101Meng AnIndividual340,000US$0.72
05 Jul 24BuyUS$981,824Meng AnIndividual1,300,000US$0.76
04 Jul 24BuyUS$36,687Meng AnIndividual50,000US$0.73
03 Jul 24BuyUS$88,343Meng AnIndividual123,000US$0.72
06 Jun 24SellUS$1,081,541Quan ZhuIndividual1,287,700US$0.84
06 Jun 24BuyUS$661,124Quan ZhuIndividual1,287,700US$0.51
21 May 24SellUS$7,914,216Yubao AnIndividual9,219,000US$0.86

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CPHG.F?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms42,907,0005.17%
Institutions65,796,3707.93%
General Public342,263,23341.2%
Individual Insiders378,857,35445.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.7%.

Top Shareholders

Top 25 shareholders own 58.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25%
Yubao An
207,737,455US$205.9m-4.25%no data
13.3%
Wai Po Young
110,050,000US$109.1m0%no data
5.17%
Lion River I N.V.
42,907,000US$42.5m0%46.46%
4.63%
Qian Li
38,424,899US$38.1m-59.3%no data
2.73%
Meng An
22,645,000US$22.4m55.8%no data
2.17%
The Vanguard Group, Inc.
18,037,474US$17.9m-0.36%no data
1.83%
FMR LLC
15,192,577US$15.1m0.02%no data
1.35%
Dimensional Fund Advisors LP
11,192,966US$11.1m0%no data
0.41%
AllianceBernstein L.P.
3,374,100US$3.3m-0.55%no data
0.31%
Norges Bank Investment Management
2,546,132US$2.5m0%no data
0.24%
Bank of Singapore Limited, Asset Management Arm
1,989,310US$2.0m0%0.16%
0.24%
BlackRock, Inc.
1,955,000US$1.9m239%no data
0.21%
First Trust Advisors LP
1,738,624US$1.7m0%no data
0.12%
Thrivent Investment Management Inc.
1,007,000US$998.3k0%no data
0.12%
China Southern Asset Management Co., Ltd.
1,000,000US$991.3k0%no data
0.1%
Artico Partners AG
845,000US$837.7k0%0.98%
0.096%
Union Asset Management Holding AG
793,000US$786.1k0%no data
0.088%
Fullgoal Fund Management Co. Ltd.
731,000US$724.7k0%no data
0.086%
AXA Investment Managers S.A.
714,000US$707.8k0%no data
0.085%
State Street Global Advisors, Inc.
707,400US$701.3k-1.12%no data
0.077%
American Century Investment Management Inc
637,012US$631.4k0%no data
0.072%
Mackenzie Financial Corporation
599,000US$593.8k0%no data
0.045%
Segall Bryant & Hamill, LLC
370,492US$367.3k0%no data
0.039%
Pharus Management SA
322,000US$319.2k0%0.05%
0.035%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
288,000US$285.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:56
End of Day Share Price 2024/12/10 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Consun Pharmaceutical Group Limited is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fangqi DaiChina Merchants Securities (HK) Co., Ltd
null nullCMB International Securities Limited
Trina ChenCredit Suisse